Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Oncology Institute (TOI) Change in Acquisitions & Divestments (2023 - 2024)

Oncology Institute's Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $10.0 million for Q3 2024.

For Q3 2024, Change in Acquisitions & Divestments rose 16.62% year-over-year to $10.0 million; the TTM value through Jun 2025 reached $10.0 million, down 83.64%, while the annual FY2024 figure was $50.0 million, 38.47% down from the prior year.
Change in Acquisitions & Divestments reached $10.0 million in Q3 2024 per TOI's latest filing, down from $20.0 million in the prior quarter.
In the past five years, Change in Acquisitions & Divestments ranged from a high of $30.1 million in Q2 2023 to a low of $8.6 million in Q3 2023.